what are the risks of glp 1 expanding role GLP-1 receptor agonists: a narrative review of current evidence and future directions Long-term Success of GLP-1s Hinges
Description
One real-world evidence study found that patients receiving GLP-1 receptor agonists had a higher risk of ulcerative colitis compared to those on DPP-4 inhibitors (a different diabetes drug class)
Despite the benefits observed in adequate glycemic control in reducing microvascular events the results are controversial in regard to atherosclerotic disease [17]
adults)
But your doctor might prescribe more than one type of insulin
The answer is technically yes, but it requires a prescription from your own physician and more self-management than most people want to handle
